Annals of Oncology

in this issue:

in this issue
Ann Oncol 17: 181; doi:10.1093/annonc/mdj144
[Extract] [Full Text] [PDF] [Request Permissions]

editorials:

A. H. Partridge

Non-adherence to endocrine therapy for breast cancer
Ann Oncol 17: 183-184; doi:10.1093/annonc/mdj141
[Extract] [Full Text] [PDF] [Request Permissions]

C.-H. Köhne and G. Folprecht

On prejudice and facts and choices
Ann Oncol 17: 185-187; doi:10.1093/annonc/mdj142
[Extract] [Full Text] [PDF] [Request Permissions]

reviews:

D. Stefanidis, K. D. Grove, W. H. Schwesinger, and C. R. Thomas, Jr

The current role of staging laparoscopy for adenocarcinoma of the pancreas: a review
Annals of Oncology Advance Access published on October 19, 2005
Ann Oncol 17: 189-199; doi:10.1093/annonc/mdj013
[Abstract] [FREE Full Text] [PDF] [CME/CE] [Request Permissions]

I. Vergote and P. Abram

Fulvestrant, a new treatment option for advanced breast cancer: tolerability versus existing agents
Annals of Oncology Advance Access published on October 26, 2005
Ann Oncol 17: 200-204; doi:10.1093/annonc/mdj047
[Abstract] [FREE Full Text] [PDF] [Request Permissions]

original articles:

breast cancer:

L. Fallowfield, L. Atkins, S. Catt, A. Cox, C. Coxon, C. Langridge, R. Morris, and M. Price

Patients' preference for administration of endocrine treatments by injection or tablets: results from a study of women with breast cancer
Annals of Oncology Advance Access published on October 20, 2005
Ann Oncol 17: 205-210; doi:10.1093/annonc/mdj044
[Abstract] [FREE Full Text] [PDF] [Request Permissions]

G. Freyer, A.-C. Braud, P. Chaibi, M. Spielmann, J.-P. Martin, G. Vilela, D. Guerin, and L. Zelek

Dealing with metastatic breast cancer in elderly women: results from a French study on a large cohort carried out by the ‘Observatory on Elderly Patients’
Annals of Oncology Advance Access published on November 15, 2005
Ann Oncol 17: 211-216; doi:10.1093/annonc/mdj043
[Abstract] [Full Text] [PDF] [Supplementary data] [Request Permissions]

P. E. Lønning

Comparing cost/utility of giving an aromatase inhibitor as monotherapy for 5 years versus sequential administration following 2–3 or 5 years of tamoxifen as adjuvant treatment for postmenopausal breast cancer
Annals of Oncology Advance Access published on November 2, 2005
Ann Oncol 17: 217-225; doi:10.1093/annonc/mdj048
[Abstract] [Full Text] [PDF] [Request Permissions]

C. X. Ma, P. Steen, K. M. Rowland, R. D. Niedringhaus, T. R. Fitch, J. W. Kugler, D. W. Hillman, E. A. Perez, J. N. Ingle, and A. A. Adjei

A phase II trial of a combination of pemetrexed and gemcitabine in patients with metastatic breast cancer: an NCCTG study
Annals of Oncology Advance Access published on November 22, 2005
Ann Oncol 17: 226-231; doi:10.1093/annonc/mdj054
[Abstract] [Full Text] [PDF] [Request Permissions]

M. Colleoni, L. Orlando, G. Sanna, A. Rocca, P. Maisonneuve, G. Peruzzotti, R. Ghisini, M. T. Sandri, L. Zorzino, F. Nolè, G. Viale, and A. Goldhirsch

Metronomic low-dose oral cyclophosphamide and methotrexate plus or minus thalidomide in metastatic breast cancer: antitumor activity and biological effects
Annals of Oncology Advance Access published on December 1, 2005
Ann Oncol 17: 232-238; doi:10.1093/annonc/mdj066
[Abstract] [Full Text] [PDF] [Request Permissions]

gastrointestinal tumors:

C. Twelves, S. Gollins, R. Grieve, and L. Samuel

A randomised cross-over trial comparing patient preference for oral capecitabine and 5-fluorouracil/leucovorin regimens in patients with advanced colorectal cancer
Annals of Oncology Advance Access published on December 12, 2005
Ann Oncol 17: 239-245; doi:10.1093/annonc/mdj023
[Abstract] [Full Text] [PDF] [Request Permissions]

A. De Paoli, S. Chiara, G. Luppi, M. L. Friso, G. D. Beretta, S. Del Prete, L. Pasetto, M. Santantonio, E. Sarti, G. Mantello, R. Innocente, S. Frustaci, R. Corvò, and R. Rosso

Capecitabine in combination with preoperative radiation therapy in locally advanced, resectable, rectal cancer: a multicentric phase II study
Annals of Oncology Advance Access published on November 9, 2005
Ann Oncol 17: 246-251; doi:10.1093/annonc/mdj041
[Abstract] [Full Text] [PDF] [Request Permissions]

P. Pfeiffer, H. Sørbye, H. Ehrsson, T. Fokstuen, J. P. Mortensen, L. Baltesgard, K. M. Tveit, D. Øgreid, H. Starkhammar, I. Wallin, C. Qvortrup, and B. Glimelius

Short-time infusion of oxaliplatin in combination with capecitabine (XELOX₃₀) as second-line therapy in patients with advanced colorectal cancer after failure to irinotecan and 5-fluorouracil
Annals of Oncology Advance Access published on November 15, 2005
Ann Oncol 17: 252-258; doi:10.1093/annonc/mdj060
[Abstract] [Full Text] [PDF] [Request Permissions]

S. W. K. Siu, R. T. T. Chan, and G. K. H. Au

Hypersensitivity reactions to oxaliplatin: experience in a single institute
Annals of Oncology Advance Access published on November 9, 2005
Ann Oncol 17: 259-261; doi:10.1093/annonc/mdj042
[Abstract] [Full Text] [PDF] [Request Permissions]

D. Nitti, J. Wils, J. Guimaraes Dos Santos, G. Fountzilas, P. F. Conte, C. Sava, A. Tres, R. C. Coombes, D. Crivellari, A. Marchet, E. Sanchez, J. M. Bliss, J. Homewood, M. L. Couvreur, E. Hall, B. Baron, E. Woods, M. Emson, E. Van Cutsem, and M. Lise

Randomized phase III trials of adjuvant FAMTX or FEMTX compared with surgery alone in resected gastric cancer. A combined analysis of the EORTC GI Group and the ICCG
Annals of Oncology Advance Access published on November 17, 2005
Ann Oncol 17: 262-269; doi:10.1093/annonc/mdj077
[Abstract] [Full Text] [PDF] [Request Permissions]

lung cancer:

M. E. R. O'Brien, D. Watkins, C. Ryan, K. Priest, C. Corbishley, A. Norton, S. Ashley, N. Rowell, and R. Sayer

A randomised trial in malignant mesothelioma (M) of early (E) versus delayed (D) chemotherapy in symptomatically stable patients: the MED trial
Annals of Oncology Advance Access published on November 29, 2005
Ann Oncol 17: 270-275; doi:10.1093/annonc/mdj073
[Abstract] [Full Text] [PDF] [Request Permissions]

urogenital tumors:

S. Krege, C. Boergermann, R. Baschek, A. Hinke, T. Pottek, S. Kliesch, K.-P. Dieckmann, P. Albers, B. Knutzen, S. Weinknecht, H.-J. Schmoll, J. Beyer, and H. Ruebben

Single agent carboplatin for CS IIA/B testicular seminoma. A phase II study of the German Testicular Cancer Study Group (GTCSG)
Annals of Oncology Advance Access published on October 27, 2005
Ann Oncol 17: 276-280; doi:10.1093/annonc/mdj039
[Abstract] [Full Text] [PDF] [Request Permissions]

hematologic malignancies:

R. Latagliata, V. Bongarzoni, I. Carmosino, A. Mengarelli, M. Breccia, P. A. Borza, M. D'Andrea, G. M. D'Elia, S. Mecarocci, S. G. Morano, M. C. Petti, F. Mandelli, and G. Alimena

Acute myelogenous leukemia in elderly patients not eligible for intensive chemotherapy: the dark side of the moon
Annals of Oncology Advance Access published on December 22, 2005
Ann Oncol 17: 281-285; doi:10.1093/annonc/mdj112
[Abstract] [Full Text] [PDF] [Request Permissions]

A. Avilés, N. Neri, and M. J. Nambo

Long-term evaluation of cardiac function in children who received anthracyclines during pregnancy
Annals of Oncology Advance Access published on November 4, 2005
Ann Oncol 17: 286-288; doi:10.1093/annonc/mdj053
[Abstract] [Full Text] [PDF] [Request Permissions]

quality of life and supportive care:

M. Karthaus, A. Kretzschmar, H. Kröning, M. Biakhov, D. Irwin, N. Marschner, C. Slabber, G. Fountzilas, A. Garin, N. G. F. Abecasis, W. Baronius, G. G. Steger, T. Südhoff, C. Giorgetti, and P. Reichardt

Dalteparin for prevention of catheter-related complications in cancer patients with central venous catheters: final results of a double-blind, placebo-controlled phase III trial
Annals of Oncology Advance Access published on November 29, 2005
Ann Oncol 17: 289-296; doi:10.1093/annonc/mdj059
[Abstract] [Full Text] [PDF] [Request Permissions]

K. Kröger, D. Weiland, C. Ose, N. Neumann, S. Weiss, C. Hirsch, K. Urbanski, S. Seeber, and M. E. Scheulen

Risk factors for venous thromboembolic events in cancer patients
Annals of Oncology Advance Access published on November 9, 2005
Ann Oncol 17: 297-303; doi:10.1093/annonc/mdj068
[Abstract] [Full Text] [PDF] [Request Permissions]

J. L. Steel, D. T. Eton, D. Cella, M. C. Olek, and B. I. Carr

Clinically meaningful changes in health-related quality of life in patients diagnosed with hepatobiliary carcinoma
Annals of Oncology Advance Access published on December 15, 2005
Ann Oncol 17: 304-312; doi:10.1093/annonc/mdj072
[Abstract] [Full Text] [PDF] [Request Permissions]

phase I and pharmacokinetics:

M. M. Mita, L. Ochoa, E. K. Rowinsky, J. Kuhn, G. Schwartz, L. A. Hammond, A. Patnaik, I.-T. Yeh, E. Izbicka, K. Berg, and A. W. Tolcher

A phase I, pharmacokinetic and biologic correlative study of oblimersen sodium (Genasense^TM, G3139) and irinotecan in patients with metastatic colorectal cancer
Annals of Oncology Advance Access published on December 1, 2005
Ann Oncol 17: 313-321; doi:10.1093/annonc/mdj067
[Abstract] [Full Text] [PDF] [Request Permissions]

F. Nolè, C. Catania, G. Sanna, K. Imadalou, E. Munzone, L. Adamoli, B. Longerey, G. Blanchot, and A. Goldhirsch

Dose-finding and pharmacokinetic study of an all-oral combination regimen of oral vinorelbine and capecitabine for patients with metastatic breast cancer
Annals of Oncology Advance Access published on November 22, 2005
Ann Oncol 17: 322-329; doi:10.1093/annonc/mdj058
[Abstract] [Full Text] [PDF] [Request Permissions]

Y. Ogawa, T. Hotta, K. Tobinai, T. Watanabe, Y. Sasaki, H. Minami, Y. Morishima, M. Ogura, and T. Seriu

Phase I and pharmacokinetic study of oral fludarabine phosphate in relapsed indolent B-cell non-Hodgkin's lymphoma
Annals of Oncology Advance Access published on November 7, 2005
Ann Oncol 17: 330-333; doi:10.1093/annonc/mdj069
[Abstract] [Full Text] [PDF] [Request Permissions]

S. J. Hotte, A. Oza, E. W. Winquist, M. Moore, E. X. Chen, S. Brown, G. R. Pond, J. E. Dancey, and H. W. Hirte

Phase I trial of UCN-01 in combination with topotecan in patients with advanced solid cancers: a Princess Margaret Hospital Phase II Consortium study
Annals of Oncology Advance Access published on November 10, 2005
Ann Oncol 17: 334-340; doi:10.1093/annonc/mdj076
[Abstract] [Full Text] [PDF] [Request Permissions]

epidemiology:

A. Tavani, L. Giordano, S. Gallus, R. Talamini, S. Franceschi, A. Giacosa, M. Montella, and C. La Vecchia

Consumption of sweet foods and breast cancer risk in Italy
Annals of Oncology Advance Access published on October 25, 2005
Ann Oncol 17: 341-345; doi:10.1093/annonc/mdj051
[Abstract] [Full Text] [PDF] [Request Permissions]

S. Gallus, P. Zuccaro, P. Colombo, G. Apolone, R. Pacifici, S. Garattini, and C. La Vecchia

Effects of new smoking regulations in Italy
Annals of Oncology Advance Access published on November 7, 2005
Ann Oncol 17: 346-347; doi:10.1093/annonc/mdj070
[Abstract] [Full Text] [PDF] [Request Permissions]

letters to the editor:

B. Oyan and Y. Koc

Is it time to discontinue using high-dose chemotherapy for salvage of patients with advanced germ-cell tumors failing first-line platinum chemotherapy?
Annals of Oncology Advance Access published on September 15, 2005
Ann Oncol 17: 349-350; doi:10.1093/annonc/mdj036
[Extract] [Full Text] [PDF] [Request Permissions]

C. Christodoulou, G. Tsakalos, E. Galani, and D. V. Skarlos

Scalp metastases and scalp cooling for chemotherapy-induced alopecia prevention
Annals of Oncology Advance Access published on September 15, 2005
Ann Oncol 17: 350; doi:10.1093/annonc/mdj008
[Extract] [Full Text] [PDF] [Request Permissions]

D. Errante, N. Mannucci, D. Bernardi, A. Bianco, and L. Salvagno

Comment on ‘Jaw avascular bone necrosis associated with long-term use of biphosphonates’
Annals of Oncology Advance Access published on September 2, 2005
Ann Oncol 17: 350-352; doi:10.1093/annonc/mdj012
[Extract] [Full Text] [PDF] [Request Permissions]

G. Ferretti, P. Carlini, E. Bria, A. Felici, D. Giannarelli, M. Ciccarese, P. Papaldo, A. Fabi, and F. Cognetti

Chemotherapy-induced amenorrhea in early breast cancer
Annals of Oncology Advance Access published on September 12, 2005
Ann Oncol 17: 352; doi:10.1093/annonc/mdj011
[Extract] [Full Text] [PDF] [Request Permissions]

J. Bogaerts, R. Sylvester, and P. Therasse

Analysis of breast cancer survival by clinical response to neoadjuvant chemoendocrine therapy
Annals of Oncology Advance Access published on August 19, 2005
Ann Oncol 17: 352-353; doi:10.1093/annonc/mdj010
[Extract] [Full Text] [PDF] [Request Permissions]

S. Cleator, A. Makris, and T. Powles

Response to letter "Analysis of breast cancer survival by clinical response to neoadjuvant chemoendocrine therapy" by Bogaerts et al. (Ann Oncol 2006; 17: 352–353)
Annals of Oncology Advance Access published on August 19, 2005
Ann Oncol 17: 353-354; doi:10.1093/annonc/mdj009
[Extract] [Full Text] [PDF] [Request Permissions]

To see an article, click its [Full Text] or [PDF] link. To review many abstracts, check the boxes to the left of the titles you want, and click the 'Get All Checked Abstract(s)' button. To see one abstract at a time, click its [Abstract] link.